Designing better delivery for medical therapies HST MD/PhD student Sayo Eweje seeks to develop new technologies for delivering RNA and protein therapies directly to the body’s cells. HST MD grad Alaleh Azhir’s mission: exploring and improving health care delivery for women Her goal is to investigate how health conditions may present differently by gender, and how to devise more effective treatments for women accordingly. HST MEMP grad Carmen Martin Alonso looks ahead to a bright future as a medical researcher Awarded a provisional patent for her work on liquid biopsy “priming agents,” Martin Alonso hopes to soon be the founding scientist of a start-up. Seeing the human behind the data Graduating physician-scientist Deborah Plana, HST MD, combines passion for analysis, improving patient care A closed-loop drug-delivery system could improve chemotherapy New CLAUDIA system, described in a paper by MIT engineers—including an HST student— could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels. Pagination First page « First Previous page Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 … Next page Next Last page Last »
Designing better delivery for medical therapies HST MD/PhD student Sayo Eweje seeks to develop new technologies for delivering RNA and protein therapies directly to the body’s cells.
HST MD grad Alaleh Azhir’s mission: exploring and improving health care delivery for women Her goal is to investigate how health conditions may present differently by gender, and how to devise more effective treatments for women accordingly.
HST MEMP grad Carmen Martin Alonso looks ahead to a bright future as a medical researcher Awarded a provisional patent for her work on liquid biopsy “priming agents,” Martin Alonso hopes to soon be the founding scientist of a start-up.
Seeing the human behind the data Graduating physician-scientist Deborah Plana, HST MD, combines passion for analysis, improving patient care
A closed-loop drug-delivery system could improve chemotherapy New CLAUDIA system, described in a paper by MIT engineers—including an HST student— could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels.
